400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / CGRP Receptor / Telcagepant
CAS No.: 781649-09-0
Synonyms: MK-0974
MK-0974 is a highly potent, selective, and orally bioavailable CGRP receptor antagonist with Ki values of 0.77 nM and 1.2 nM for human and rhesus CGRP receptors respectively, displaying > 1500-fold lower affinity for the canine and rat receptors.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00690989 | - | - | Completed | - | - |
NCT02473692 | - | - | Withdrawn(Delays in start date... more >> led to termination of the study prior to recruitment of participants.) Collapse << | December 2017 | - |
NCT01421277 | - | - | Terminated | - | - |
实验方案
技术信息
CAS号 | 781649-09-0 | 储存条件 |
|
|
分子式 | C26H27F5N6O3 | 运输 | 蓝冰 | |
分子量 | 566.52 | 别名 | MK-0974 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00690989 | - | - | Completed | - | - |
NCT02473692 | - | - | Withdrawn(Delays in start date... more >> led to termination of the study prior to recruitment of participants.) Collapse << | December 2017 | - |
NCT01421277 | - | - | Terminated | - | - |
NCT01421277 | - | - | Terminated | - | - |
NCT01706003 | - | - | Enrolling by invitation | October 2018 | United States, Texas ... more >> Universit of Texas Southwestern Dallas, Texas, United States, 75390 Collapse << |
NCT00442936 | Migraine | Phase 3 | Completed | - | - |
NCT00246337 | - | - | Completed | - | - |
NCT00432237 | Migraine | Phase 3 | Completed | - | - |
NCT00246337 | Migraine | Phase 2 | Completed | - | - |
NCT00442936 | - | - | Completed | - | - |
NCT00443209 | Migraine | Phase 3 | Completed | - | - |
NCT00443209 | - | - | Completed | - | - |
NCT00758836 | - | - | Completed | - | - |
NCT00432237 | - | - | Completed | - | - |
NCT00758836 | Migraine | Phase 2 | Completed | - | - |
NCT00483704 | Migraines | Phase 3 | Completed | - | - |
NCT00966030 | Migraine | Phase 1 | Completed | - | - |
NCT00965887 | Migraine | Phase 1 | Completed | - | - |
NCT01209741 | Migraine | Phase 1 | Completed | - | - |
NCT00483704 | - | - | Completed | - | - |
NCT00701389 | Migraine Disorders | Phase 1 | Completed | - | - |
NCT00701389 | - | - | Completed | - | - |
NCT00662818 | Migraine Disorders ... more >> Heart Disease Cerebrovascular Accident TIA (Transient Ischemic Attack) Vascular Diseases Peripheral Vascular Diseases Collapse << | Phase 3 | Completed | - | - |
NCT00797667 | - | - | Terminated(The study was termi... more >>nated based on a recommendation of the DSMB following the identification of two patients with significant elevations in serum transaminases) Collapse << | - | - |
NCT00662818 | - | - | Completed | - | - |
NCT01315847 | - | - | Completed | - | - |
NCT01294709 | Angina Pectoris ... more >> Coronary Heart Disease Calcitonin Gene-related Peptide Receptor Collapse << | Phase 1 | Completed | - | - |
NCT01125774 | Migraine | Phase 2 Phase 3 | Completed | - | - |
NCT01294709 | - | - | Completed | - | - |
NCT01125774 | - | - | Completed | - | - |
NCT00797667 | Migraine | Phase 2 | Terminated(The study was termi... more >>nated based on a recommendation of the DSMB following the identification of two patients with significant elevations in serum transaminases) Collapse << | - | - |
NCT01315847 | Migraine | Phase 1 | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网